nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—prostate cancer	0.411	1	CbGaD
Moxifloxacin—TOP2A—Mitoxantrone—prostate cancer	0.134	0.349	CbGbCtD
Moxifloxacin—TOP2A—Epirubicin—prostate cancer	0.109	0.282	CbGbCtD
Moxifloxacin—TOP2A—Etoposide—prostate cancer	0.0848	0.22	CbGbCtD
Moxifloxacin—TOP2A—Doxorubicin—prostate cancer	0.0578	0.15	CbGbCtD
Moxifloxacin—TOP2A—Docetaxel—Cabazitaxel—prostate cancer	0.000941	0.267	CbGdCrCtD
Moxifloxacin—TOP2A—Paclitaxel—Cabazitaxel—prostate cancer	0.000649	0.184	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SERPINB10—prostate cancer	0.000514	0.0435	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—prostate cancer	0.000476	0.0403	CbGpPWpGaD
Moxifloxacin—Enoxacin—TOP2A—prostate cancer	0.000445	0.136	CrCbGaD
Moxifloxacin—Sparfloxacin—TOP2A—prostate cancer	0.00041	0.126	CrCbGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WRN—prostate cancer	0.000389	0.033	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—AURKA—prostate cancer	0.000384	0.0325	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—ZFHX3—prostate cancer	0.000374	0.0316	CbGpPWpGaD
Moxifloxacin—Lomefloxacin—TOP2A—prostate cancer	0.000337	0.103	CrCbGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—prostate cancer	0.000299	0.0253	CbGpPWpGaD
Moxifloxacin—Ofloxacin—TOP2A—prostate cancer	0.000288	0.0884	CrCbGaD
Moxifloxacin—Levofloxacin—TOP2A—prostate cancer	0.000288	0.0884	CrCbGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—STMN1—prostate cancer	0.000285	0.0241	CbGpPWpGaD
Moxifloxacin—Ciprofloxacin—TOP2A—prostate cancer	0.000278	0.0853	CrCbGaD
Moxifloxacin—TOP2A—Paclitaxel—Docetaxel—prostate cancer	0.00027	0.0765	CbGdCrCtD
Moxifloxacin—Norfloxacin—TOP2A—prostate cancer	0.000234	0.0717	CrCbGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—NAGLU—prostate cancer	0.000226	0.0192	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—PRKDC—prostate cancer	0.00022	0.0187	CbGpPWpGaD
Moxifloxacin—Ciprofloxacin—CYP3A5—prostate cancer	0.00022	0.0674	CrCbGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CD82—prostate cancer	0.000213	0.0181	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—ID3—prostate cancer	0.000205	0.0173	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—APC—prostate cancer	0.000203	0.0172	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—prostate cancer	0.000198	0.0167	CbGpPWpGaD
Moxifloxacin—TOP2A—Fulvestrant—Estradiol—prostate cancer	0.000197	0.0558	CbGdCrCtD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—prostate cancer	0.000191	0.0162	CbGpPWpGaD
Moxifloxacin—Norfloxacin—CYP3A5—prostate cancer	0.000184	0.0566	CrCbGaD
Moxifloxacin—Norfloxacin—CYP2A6—prostate cancer	0.000179	0.0548	CrCbGaD
Moxifloxacin—TOP2A—Podofilox—Etoposide—prostate cancer	0.000173	0.0491	CbGdCrCtD
Moxifloxacin—TOP2A—Teniposide—Etoposide—prostate cancer	0.000173	0.0491	CbGdCrCtD
Moxifloxacin—TOP2A—Levorphanol—Estrone—prostate cancer	0.000172	0.0487	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—DAG1—prostate cancer	0.000169	0.0143	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—prostate cancer	0.000164	0.0139	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STMN1—prostate cancer	0.000152	0.0129	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ATM—prostate cancer	0.000147	0.0125	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—GSK3B—prostate cancer	0.000132	0.0112	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—prostate cancer	0.000131	0.0111	CbGpPWpGaD
Moxifloxacin—TOP2A—Levorphanol—Estradiol—prostate cancer	0.00013	0.0369	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle—PSMC3IP—prostate cancer	0.000128	0.0108	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—HNF1B—prostate cancer	0.000126	0.0107	CbGpPWpGaD
Moxifloxacin—Norfloxacin—CYP1A1—prostate cancer	0.000125	0.0384	CrCbGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—HSP90AB1—prostate cancer	0.00012	0.0101	CbGpPWpGaD
Moxifloxacin—TOP2A—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.000119	0.0337	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EIF2AK2—prostate cancer	0.000115	0.00975	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—prostate cancer	0.000115	0.00972	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—USO1—prostate cancer	0.000114	0.00967	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PCNT—prostate cancer	0.000114	0.00967	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PRKDC—prostate cancer	0.000113	0.00955	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—prostate cancer	0.000109	0.00924	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—prostate cancer	0.000109	0.0092	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—REC8—prostate cancer	0.000109	0.00919	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—AHR—prostate cancer	0.000108	0.00911	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—MYC—prostate cancer	0.000106	0.00896	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—EGFR—prostate cancer	0.000104	0.00877	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—USO1—prostate cancer	0.000102	0.00864	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—PCNT—prostate cancer	0.000102	0.00864	CbGpPWpGaD
Moxifloxacin—Levofloxacin—CYP3A4—prostate cancer	9.85e-05	0.0302	CrCbGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—HPGDS—prostate cancer	9.79e-05	0.00829	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—prostate cancer	9.73e-05	0.00824	CbGpPWpGaD
Moxifloxacin—Ciprofloxacin—CYP3A4—prostate cancer	9.51e-05	0.0292	CrCbGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ACHE—prostate cancer	9.5e-05	0.00804	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—prostate cancer	9.39e-05	0.00795	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFBR1—prostate cancer	9.28e-05	0.00786	CbGpPWpGaD
Moxifloxacin—TOP2A—Idarubicin—Epirubicin—prostate cancer	9.03e-05	0.0256	CbGdCrCtD
Moxifloxacin—TOP2A—Doxorubicin—Epirubicin—prostate cancer	9.03e-05	0.0256	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Epirubicin—prostate cancer	9.03e-05	0.0256	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—THBS1—prostate cancer	8.86e-05	0.0075	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—prostate cancer	8.73e-05	0.00739	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—TP53—prostate cancer	8.69e-05	0.00736	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—prostate cancer	8.45e-05	0.00716	CbGpPWpGaD
Moxifloxacin—TOP2A—Epirubicin—Doxorubicin—prostate cancer	8.36e-05	0.0237	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Doxorubicin—prostate cancer	8.36e-05	0.0237	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Doxorubicin—prostate cancer	8.36e-05	0.0237	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—prostate cancer	8.31e-05	0.00703	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—NCOA2—prostate cancer	8.22e-05	0.00696	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—EZH2—prostate cancer	8.11e-05	0.00687	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—prostate cancer	8.08e-05	0.00684	CbGpPWpGaD
Moxifloxacin—Norfloxacin—CYP3A4—prostate cancer	7.99e-05	0.0245	CrCbGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—prostate cancer	7.83e-05	0.00663	CbGpPWpGaD
Moxifloxacin—TOP2A—Norethindrone—Ethinyl Estradiol—prostate cancer	7.74e-05	0.0219	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—prostate cancer	7.59e-05	0.00643	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP9—prostate cancer	7.52e-05	0.00636	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TH—prostate cancer	7.47e-05	0.00632	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGR1—prostate cancer	7.33e-05	0.00621	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—prostate cancer	7.11e-05	0.00602	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—EGR1—prostate cancer	7.04e-05	0.00596	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—NGFR—prostate cancer	6.99e-05	0.00592	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—prostate cancer	6.92e-05	0.00586	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RXRA—prostate cancer	6.87e-05	0.00581	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—prostate cancer	6.64e-05	0.00562	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	6.43e-05	0.00545	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	6.31e-05	0.00534	CbGpPWpGaD
Moxifloxacin—TOP2A—Levonorgestrel—Ethinyl Estradiol—prostate cancer	6.16e-05	0.0175	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	6.12e-05	0.00518	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—prostate cancer	6.06e-05	0.00513	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—SIRT1—prostate cancer	6.06e-05	0.00513	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	5.9e-05	0.00499	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TYMS—prostate cancer	5.88e-05	0.00497	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—prostate cancer	5.78e-05	0.00489	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	5.62e-05	0.00476	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—prostate cancer	5.59e-05	0.00473	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—HIST1H2BG—prostate cancer	5.47e-05	0.00463	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—HIST1H4H—prostate cancer	5.28e-05	0.00447	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PPARA—prostate cancer	5.04e-05	0.00426	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAD1L1—prostate cancer	4.97e-05	0.00421	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—HIST1H2BG—prostate cancer	4.89e-05	0.00414	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	4.79e-05	0.00406	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—LEP—prostate cancer	4.78e-05	0.00405	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	4.75e-05	0.00402	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—HIST1H4H—prostate cancer	4.73e-05	0.004	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	4.64e-05	0.00393	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—prostate cancer	4.64e-05	0.00393	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	4.49e-05	0.0038	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAD1L1—prostate cancer	4.44e-05	0.00376	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	4.44e-05	0.00376	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—prostate cancer	4.26e-05	0.00361	CbGpPWpGaD
Moxifloxacin—TOP2A—Methyltestosterone—Prednisone—prostate cancer	4.17e-05	0.0118	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	4.16e-05	0.00353	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—GSK3B—prostate cancer	4.14e-05	0.0035	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	4.11e-05	0.00348	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—AURKA—prostate cancer	4.11e-05	0.00348	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—NBN—prostate cancer	4.09e-05	0.00346	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—prostate cancer	4.07e-05	0.00344	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MLH1—prostate cancer	4.06e-05	0.00344	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	3.97e-05	0.00337	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—prostate cancer	3.93e-05	0.00333	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—prostate cancer	3.81e-05	0.00322	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	3.78e-05	0.0032	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—SERPINE1—prostate cancer	3.75e-05	0.00317	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—AURKA—prostate cancer	3.67e-05	0.00311	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	3.59e-05	0.00304	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—APEX1—prostate cancer	3.57e-05	0.00302	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	3.54e-05	0.003	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	3.49e-05	0.00295	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—prostate cancer	3.44e-05	0.00292	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	3.41e-05	0.00289	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CHEK2—prostate cancer	3.29e-05	0.00278	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—prostate cancer	3.26e-05	0.00276	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	3.23e-05	0.00273	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—APEX1—prostate cancer	3.19e-05	0.0027	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	3.17e-05	0.00268	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	3.08e-05	0.00261	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—BRCA1—prostate cancer	3.08e-05	0.00261	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND2—prostate cancer	3.08e-05	0.00261	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	3.05e-05	0.00258	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	2.98e-05	0.00252	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	2.97e-05	0.00252	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—prostate cancer	2.96e-05	0.00251	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PTEN—prostate cancer	2.86e-05	0.00242	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	2.84e-05	0.0024	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—BRCA2—prostate cancer	2.79e-05	0.00236	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	2.76e-05	0.00234	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—EP300—prostate cancer	2.72e-05	0.00231	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	2.69e-05	0.00227	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TYMS—prostate cancer	2.65e-05	0.00224	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	2.47e-05	0.00209	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	2.47e-05	0.00209	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	2.42e-05	0.00205	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TERT—prostate cancer	2.31e-05	0.00195	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	2.28e-05	0.00193	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	2.1e-05	0.00178	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—ATM—prostate cancer	2.07e-05	0.00176	CbGpPWpGaD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.04e-05	0.000111	CcSEcCtD
Moxifloxacin—Dyspnoea—Docetaxel—prostate cancer	2.03e-05	0.00011	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.03e-05	0.00172	CbGpPWpGaD
Moxifloxacin—Somnolence—Docetaxel—prostate cancer	2.03e-05	0.00011	CcSEcCtD
Moxifloxacin—Discomfort—Prednisone—prostate cancer	2.03e-05	0.00011	CcSEcCtD
Moxifloxacin—Eye disorder—Epirubicin—prostate cancer	2.02e-05	0.00011	CcSEcCtD
Moxifloxacin—Hypersensitivity—Etoposide—prostate cancer	2.02e-05	0.00011	CcSEcCtD
Moxifloxacin—Tinnitus—Epirubicin—prostate cancer	2.02e-05	0.00011	CcSEcCtD
Moxifloxacin—Haemoglobin—Doxorubicin—prostate cancer	2.01e-05	0.000109	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.01e-05	0.000109	CcSEcCtD
Moxifloxacin—Cardiac disorder—Epirubicin—prostate cancer	2.01e-05	0.000109	CcSEcCtD
Moxifloxacin—Rhinitis—Doxorubicin—prostate cancer	2.01e-05	0.000109	CcSEcCtD
Moxifloxacin—Dyspepsia—Docetaxel—prostate cancer	2.01e-05	0.000109	CcSEcCtD
Moxifloxacin—Hepatitis—Doxorubicin—prostate cancer	2e-05	0.000109	CcSEcCtD
Moxifloxacin—Haemorrhage—Doxorubicin—prostate cancer	2e-05	0.000109	CcSEcCtD
Moxifloxacin—Insomnia—Capecitabine—prostate cancer	2e-05	0.000108	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Doxorubicin—prostate cancer	1.99e-05	0.000108	CcSEcCtD
Moxifloxacin—Pharyngitis—Doxorubicin—prostate cancer	1.99e-05	0.000108	CcSEcCtD
Moxifloxacin—Paraesthesia—Capecitabine—prostate cancer	1.98e-05	0.000108	CcSEcCtD
Moxifloxacin—Decreased appetite—Docetaxel—prostate cancer	1.98e-05	0.000108	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Doxorubicin—prostate cancer	1.98e-05	0.000107	CcSEcCtD
Moxifloxacin—Oedema peripheral—Doxorubicin—prostate cancer	1.97e-05	0.000107	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Docetaxel—prostate cancer	1.97e-05	0.000107	CcSEcCtD
Moxifloxacin—Asthenia—Etoposide—prostate cancer	1.97e-05	0.000107	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Doxorubicin—prostate cancer	1.97e-05	0.000107	CcSEcCtD
Moxifloxacin—Dyspnoea—Capecitabine—prostate cancer	1.97e-05	0.000107	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Prednisone—prostate cancer	1.97e-05	0.000107	CcSEcCtD
Moxifloxacin—Oedema—Prednisone—prostate cancer	1.97e-05	0.000107	CcSEcCtD
Moxifloxacin—Fatigue—Docetaxel—prostate cancer	1.97e-05	0.000107	CcSEcCtD
Moxifloxacin—Angiopathy—Epirubicin—prostate cancer	1.97e-05	0.000107	CcSEcCtD
Moxifloxacin—Urethral disorder—Doxorubicin—prostate cancer	1.96e-05	0.000107	CcSEcCtD
Moxifloxacin—Nausea—Mitoxantrone—prostate cancer	1.96e-05	0.000106	CcSEcCtD
Moxifloxacin—Immune system disorder—Epirubicin—prostate cancer	1.96e-05	0.000106	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Epirubicin—prostate cancer	1.95e-05	0.000106	CcSEcCtD
Moxifloxacin—Pain—Docetaxel—prostate cancer	1.95e-05	0.000106	CcSEcCtD
Moxifloxacin—Constipation—Docetaxel—prostate cancer	1.95e-05	0.000106	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—TP53—prostate cancer	1.95e-05	0.00165	CbGpPWpGaD
Moxifloxacin—Dyspepsia—Capecitabine—prostate cancer	1.94e-05	0.000105	CcSEcCtD
Moxifloxacin—Chills—Epirubicin—prostate cancer	1.94e-05	0.000105	CcSEcCtD
Moxifloxacin—Pruritus—Etoposide—prostate cancer	1.94e-05	0.000105	CcSEcCtD
Moxifloxacin—Shock—Prednisone—prostate cancer	1.94e-05	0.000105	CcSEcCtD
Moxifloxacin—Arrhythmia—Epirubicin—prostate cancer	1.93e-05	0.000105	CcSEcCtD
Moxifloxacin—Visual impairment—Doxorubicin—prostate cancer	1.93e-05	0.000105	CcSEcCtD
Moxifloxacin—Nervous system disorder—Prednisone—prostate cancer	1.93e-05	0.000105	CcSEcCtD
Moxifloxacin—Tachycardia—Prednisone—prostate cancer	1.92e-05	0.000104	CcSEcCtD
Moxifloxacin—Decreased appetite—Capecitabine—prostate cancer	1.92e-05	0.000104	CcSEcCtD
Moxifloxacin—Skin disorder—Prednisone—prostate cancer	1.91e-05	0.000104	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Capecitabine—prostate cancer	1.91e-05	0.000103	CcSEcCtD
Moxifloxacin—Fatigue—Capecitabine—prostate cancer	1.9e-05	0.000103	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Prednisone—prostate cancer	1.9e-05	0.000103	CcSEcCtD
Moxifloxacin—Mental disorder—Epirubicin—prostate cancer	1.9e-05	0.000103	CcSEcCtD
Moxifloxacin—Erythema multiforme—Doxorubicin—prostate cancer	1.89e-05	0.000103	CcSEcCtD
Moxifloxacin—Constipation—Capecitabine—prostate cancer	1.89e-05	0.000102	CcSEcCtD
Moxifloxacin—Pain—Capecitabine—prostate cancer	1.89e-05	0.000102	CcSEcCtD
Moxifloxacin—Malnutrition—Epirubicin—prostate cancer	1.89e-05	0.000102	CcSEcCtD
Moxifloxacin—Erythema—Epirubicin—prostate cancer	1.89e-05	0.000102	CcSEcCtD
Moxifloxacin—Feeling abnormal—Docetaxel—prostate cancer	1.88e-05	0.000102	CcSEcCtD
Moxifloxacin—Diarrhoea—Etoposide—prostate cancer	1.88e-05	0.000102	CcSEcCtD
Moxifloxacin—Anorexia—Prednisone—prostate cancer	1.88e-05	0.000102	CcSEcCtD
Moxifloxacin—Eye disorder—Doxorubicin—prostate cancer	1.87e-05	0.000102	CcSEcCtD
Moxifloxacin—Tinnitus—Doxorubicin—prostate cancer	1.87e-05	0.000101	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Docetaxel—prostate cancer	1.87e-05	0.000101	CcSEcCtD
Moxifloxacin—Cardiac disorder—Doxorubicin—prostate cancer	1.86e-05	0.000101	CcSEcCtD
Moxifloxacin—Flatulence—Epirubicin—prostate cancer	1.86e-05	0.000101	CcSEcCtD
Moxifloxacin—Tension—Epirubicin—prostate cancer	1.85e-05	0.0001	CcSEcCtD
Moxifloxacin—Dysgeusia—Epirubicin—prostate cancer	1.85e-05	0.0001	CcSEcCtD
Moxifloxacin—Nervousness—Epirubicin—prostate cancer	1.83e-05	9.93e-05	CcSEcCtD
Moxifloxacin—Back pain—Epirubicin—prostate cancer	1.82e-05	9.89e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Capecitabine—prostate cancer	1.82e-05	9.87e-05	CcSEcCtD
Moxifloxacin—Angiopathy—Doxorubicin—prostate cancer	1.82e-05	9.86e-05	CcSEcCtD
Moxifloxacin—Dizziness—Etoposide—prostate cancer	1.82e-05	9.84e-05	CcSEcCtD
Moxifloxacin—Muscle spasms—Epirubicin—prostate cancer	1.81e-05	9.83e-05	CcSEcCtD
Moxifloxacin—Immune system disorder—Doxorubicin—prostate cancer	1.81e-05	9.82e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Capecitabine—prostate cancer	1.81e-05	9.79e-05	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Doxorubicin—prostate cancer	1.81e-05	9.79e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Docetaxel—prostate cancer	1.8e-05	9.78e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Docetaxel—prostate cancer	1.8e-05	9.78e-05	CcSEcCtD
Moxifloxacin—Chills—Doxorubicin—prostate cancer	1.8e-05	9.75e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Prednisone—prostate cancer	1.79e-05	9.72e-05	CcSEcCtD
Moxifloxacin—Arrhythmia—Doxorubicin—prostate cancer	1.79e-05	9.71e-05	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—IL6—prostate cancer	1.78e-05	0.00151	CbGpPWpGaD
Moxifloxacin—Insomnia—Prednisone—prostate cancer	1.78e-05	9.65e-05	CcSEcCtD
Moxifloxacin—Vision blurred—Epirubicin—prostate cancer	1.78e-05	9.64e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Prednisone—prostate cancer	1.77e-05	9.58e-05	CcSEcCtD
Moxifloxacin—Mental disorder—Doxorubicin—prostate cancer	1.76e-05	9.52e-05	CcSEcCtD
Moxifloxacin—Urticaria—Capecitabine—prostate cancer	1.75e-05	9.51e-05	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Epirubicin—prostate cancer	1.75e-05	9.49e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Capecitabine—prostate cancer	1.75e-05	9.47e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Capecitabine—prostate cancer	1.75e-05	9.47e-05	CcSEcCtD
Moxifloxacin—Vomiting—Etoposide—prostate cancer	1.75e-05	9.46e-05	CcSEcCtD
Moxifloxacin—Malnutrition—Doxorubicin—prostate cancer	1.74e-05	9.46e-05	CcSEcCtD
Moxifloxacin—Erythema—Doxorubicin—prostate cancer	1.74e-05	9.46e-05	CcSEcCtD
Moxifloxacin—Anaemia—Epirubicin—prostate cancer	1.74e-05	9.45e-05	CcSEcCtD
Moxifloxacin—Agitation—Epirubicin—prostate cancer	1.73e-05	9.4e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Prednisone—prostate cancer	1.73e-05	9.39e-05	CcSEcCtD
Moxifloxacin—Rash—Etoposide—prostate cancer	1.73e-05	9.39e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Etoposide—prostate cancer	1.73e-05	9.38e-05	CcSEcCtD
Moxifloxacin—Headache—Etoposide—prostate cancer	1.72e-05	9.33e-05	CcSEcCtD
Moxifloxacin—Flatulence—Doxorubicin—prostate cancer	1.72e-05	9.32e-05	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.71e-05	0.00145	CbGpPWpGaD
Moxifloxacin—Tension—Doxorubicin—prostate cancer	1.71e-05	9.28e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Prednisone—prostate cancer	1.71e-05	9.27e-05	CcSEcCtD
Moxifloxacin—Dysgeusia—Doxorubicin—prostate cancer	1.71e-05	9.26e-05	CcSEcCtD
Moxifloxacin—Malaise—Epirubicin—prostate cancer	1.7e-05	9.22e-05	CcSEcCtD
Moxifloxacin—Fatigue—Prednisone—prostate cancer	1.7e-05	9.2e-05	CcSEcCtD
Moxifloxacin—Nervousness—Doxorubicin—prostate cancer	1.69e-05	9.19e-05	CcSEcCtD
Moxifloxacin—Vertigo—Epirubicin—prostate cancer	1.69e-05	9.19e-05	CcSEcCtD
Moxifloxacin—Syncope—Epirubicin—prostate cancer	1.69e-05	9.17e-05	CcSEcCtD
Moxifloxacin—Leukopenia—Epirubicin—prostate cancer	1.69e-05	9.15e-05	CcSEcCtD
Moxifloxacin—Back pain—Doxorubicin—prostate cancer	1.69e-05	9.15e-05	CcSEcCtD
Moxifloxacin—Constipation—Prednisone—prostate cancer	1.68e-05	9.12e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Docetaxel—prostate cancer	1.68e-05	9.11e-05	CcSEcCtD
Moxifloxacin—Muscle spasms—Doxorubicin—prostate cancer	1.68e-05	9.09e-05	CcSEcCtD
Moxifloxacin—Palpitations—Epirubicin—prostate cancer	1.67e-05	9.03e-05	CcSEcCtD
Moxifloxacin—Loss of consciousness—Epirubicin—prostate cancer	1.66e-05	8.99e-05	CcSEcCtD
Moxifloxacin—Cough—Epirubicin—prostate cancer	1.65e-05	8.92e-05	CcSEcCtD
Moxifloxacin—Vision blurred—Doxorubicin—prostate cancer	1.64e-05	8.92e-05	CcSEcCtD
Moxifloxacin—Asthenia—Docetaxel—prostate cancer	1.64e-05	8.88e-05	CcSEcCtD
Moxifloxacin—Convulsion—Epirubicin—prostate cancer	1.63e-05	8.86e-05	CcSEcCtD
Moxifloxacin—Nausea—Etoposide—prostate cancer	1.63e-05	8.84e-05	CcSEcCtD
Moxifloxacin—Hypertension—Epirubicin—prostate cancer	1.63e-05	8.83e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Capecitabine—prostate cancer	1.63e-05	8.82e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Prednisone—prostate cancer	1.62e-05	8.79e-05	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Doxorubicin—prostate cancer	1.62e-05	8.78e-05	CcSEcCtD
Moxifloxacin—Pruritus—Docetaxel—prostate cancer	1.61e-05	8.75e-05	CcSEcCtD
Moxifloxacin—Anaemia—Doxorubicin—prostate cancer	1.61e-05	8.74e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Prednisone—prostate cancer	1.61e-05	8.72e-05	CcSEcCtD
Moxifloxacin—Myalgia—Epirubicin—prostate cancer	1.61e-05	8.7e-05	CcSEcCtD
Moxifloxacin—Chest pain—Epirubicin—prostate cancer	1.61e-05	8.7e-05	CcSEcCtD
Moxifloxacin—Arthralgia—Epirubicin—prostate cancer	1.61e-05	8.7e-05	CcSEcCtD
Moxifloxacin—Agitation—Doxorubicin—prostate cancer	1.6e-05	8.69e-05	CcSEcCtD
Moxifloxacin—Anxiety—Epirubicin—prostate cancer	1.6e-05	8.67e-05	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.59e-05	8.64e-05	CcSEcCtD
Moxifloxacin—Discomfort—Epirubicin—prostate cancer	1.59e-05	8.6e-05	CcSEcCtD
Moxifloxacin—Asthenia—Capecitabine—prostate cancer	1.58e-05	8.59e-05	CcSEcCtD
Moxifloxacin—Malaise—Doxorubicin—prostate cancer	1.57e-05	8.53e-05	CcSEcCtD
Moxifloxacin—Dry mouth—Epirubicin—prostate cancer	1.57e-05	8.51e-05	CcSEcCtD
Moxifloxacin—Vertigo—Doxorubicin—prostate cancer	1.57e-05	8.5e-05	CcSEcCtD
Moxifloxacin—Syncope—Doxorubicin—prostate cancer	1.56e-05	8.48e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—prostate cancer	1.56e-05	0.00132	CbGpPWpGaD
Moxifloxacin—Urticaria—Prednisone—prostate cancer	1.56e-05	8.48e-05	CcSEcCtD
Moxifloxacin—Pruritus—Capecitabine—prostate cancer	1.56e-05	8.47e-05	CcSEcCtD
Moxifloxacin—Leukopenia—Doxorubicin—prostate cancer	1.56e-05	8.47e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Docetaxel—prostate cancer	1.56e-05	8.46e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Prednisone—prostate cancer	1.56e-05	8.43e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Prednisone—prostate cancer	1.56e-05	8.43e-05	CcSEcCtD
Moxifloxacin—Confusional state—Epirubicin—prostate cancer	1.55e-05	8.41e-05	CcSEcCtD
Moxifloxacin—Palpitations—Doxorubicin—prostate cancer	1.54e-05	8.36e-05	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Epirubicin—prostate cancer	1.54e-05	8.34e-05	CcSEcCtD
Moxifloxacin—Oedema—Epirubicin—prostate cancer	1.54e-05	8.34e-05	CcSEcCtD
Moxifloxacin—Loss of consciousness—Doxorubicin—prostate cancer	1.53e-05	8.31e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—MDM2—prostate cancer	1.53e-05	0.0013	CbGpPWpGaD
Moxifloxacin—Cough—Doxorubicin—prostate cancer	1.52e-05	8.25e-05	CcSEcCtD
Moxifloxacin—Shock—Epirubicin—prostate cancer	1.51e-05	8.21e-05	CcSEcCtD
Moxifloxacin—Convulsion—Doxorubicin—prostate cancer	1.51e-05	8.2e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Capecitabine—prostate cancer	1.51e-05	8.19e-05	CcSEcCtD
Moxifloxacin—Nervous system disorder—Epirubicin—prostate cancer	1.51e-05	8.18e-05	CcSEcCtD
Moxifloxacin—Dizziness—Docetaxel—prostate cancer	1.51e-05	8.18e-05	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Epirubicin—prostate cancer	1.51e-05	8.17e-05	CcSEcCtD
Moxifloxacin—Hypertension—Doxorubicin—prostate cancer	1.51e-05	8.17e-05	CcSEcCtD
Moxifloxacin—Tachycardia—Epirubicin—prostate cancer	1.5e-05	8.14e-05	CcSEcCtD
Moxifloxacin—Skin disorder—Epirubicin—prostate cancer	1.49e-05	8.1e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—prostate cancer	1.49e-05	0.00126	CbGpPWpGaD
Moxifloxacin—Hyperhidrosis—Epirubicin—prostate cancer	1.49e-05	8.07e-05	CcSEcCtD
Moxifloxacin—Arthralgia—Doxorubicin—prostate cancer	1.49e-05	8.05e-05	CcSEcCtD
Moxifloxacin—Chest pain—Doxorubicin—prostate cancer	1.49e-05	8.05e-05	CcSEcCtD
Moxifloxacin—Myalgia—Doxorubicin—prostate cancer	1.49e-05	8.05e-05	CcSEcCtD
Moxifloxacin—Anxiety—Doxorubicin—prostate cancer	1.48e-05	8.03e-05	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.47e-05	8e-05	CcSEcCtD
Moxifloxacin—Discomfort—Doxorubicin—prostate cancer	1.47e-05	7.96e-05	CcSEcCtD
Moxifloxacin—Anorexia—Epirubicin—prostate cancer	1.47e-05	7.95e-05	CcSEcCtD
Moxifloxacin—Dizziness—Capecitabine—prostate cancer	1.46e-05	7.92e-05	CcSEcCtD
Moxifloxacin—Dry mouth—Doxorubicin—prostate cancer	1.45e-05	7.88e-05	CcSEcCtD
Moxifloxacin—Vomiting—Docetaxel—prostate cancer	1.45e-05	7.87e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Prednisone—prostate cancer	1.45e-05	7.86e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—prostate cancer	1.44e-05	0.00122	CbGpPWpGaD
Moxifloxacin—Rash—Docetaxel—prostate cancer	1.44e-05	7.8e-05	CcSEcCtD
Moxifloxacin—Hypotension—Epirubicin—prostate cancer	1.44e-05	7.8e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Docetaxel—prostate cancer	1.44e-05	7.79e-05	CcSEcCtD
Moxifloxacin—Confusional state—Doxorubicin—prostate cancer	1.44e-05	7.78e-05	CcSEcCtD
Moxifloxacin—Headache—Docetaxel—prostate cancer	1.43e-05	7.75e-05	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Doxorubicin—prostate cancer	1.42e-05	7.72e-05	CcSEcCtD
Moxifloxacin—Oedema—Doxorubicin—prostate cancer	1.42e-05	7.72e-05	CcSEcCtD
Moxifloxacin—Asthenia—Prednisone—prostate cancer	1.41e-05	7.65e-05	CcSEcCtD
Moxifloxacin—Vomiting—Capecitabine—prostate cancer	1.4e-05	7.62e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.4e-05	7.6e-05	CcSEcCtD
Moxifloxacin—Shock—Doxorubicin—prostate cancer	1.4e-05	7.6e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1B—prostate cancer	1.4e-05	0.00118	CbGpPWpGaD
Moxifloxacin—Nervous system disorder—Doxorubicin—prostate cancer	1.4e-05	7.57e-05	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Doxorubicin—prostate cancer	1.39e-05	7.56e-05	CcSEcCtD
Moxifloxacin—Rash—Capecitabine—prostate cancer	1.39e-05	7.55e-05	CcSEcCtD
Moxifloxacin—Pruritus—Prednisone—prostate cancer	1.39e-05	7.55e-05	CcSEcCtD
Moxifloxacin—Insomnia—Epirubicin—prostate cancer	1.39e-05	7.55e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Capecitabine—prostate cancer	1.39e-05	7.54e-05	CcSEcCtD
Moxifloxacin—Tachycardia—Doxorubicin—prostate cancer	1.39e-05	7.54e-05	CcSEcCtD
Moxifloxacin—Headache—Capecitabine—prostate cancer	1.38e-05	7.5e-05	CcSEcCtD
Moxifloxacin—Skin disorder—Doxorubicin—prostate cancer	1.38e-05	7.5e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Epirubicin—prostate cancer	1.38e-05	7.49e-05	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Doxorubicin—prostate cancer	1.38e-05	7.46e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—EP300—prostate cancer	1.37e-05	0.00116	CbGpPWpGaD
Moxifloxacin—Dyspnoea—Epirubicin—prostate cancer	1.37e-05	7.44e-05	CcSEcCtD
Moxifloxacin—Somnolence—Epirubicin—prostate cancer	1.37e-05	7.42e-05	CcSEcCtD
Moxifloxacin—Anorexia—Doxorubicin—prostate cancer	1.36e-05	7.36e-05	CcSEcCtD
Moxifloxacin—Nausea—Docetaxel—prostate cancer	1.36e-05	7.35e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Epirubicin—prostate cancer	1.35e-05	7.34e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Prednisone—prostate cancer	1.35e-05	7.3e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Epirubicin—prostate cancer	1.34e-05	7.25e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CCND1—prostate cancer	1.33e-05	0.00113	CbGpPWpGaD
Moxifloxacin—Hypotension—Doxorubicin—prostate cancer	1.33e-05	7.21e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Epirubicin—prostate cancer	1.33e-05	7.2e-05	CcSEcCtD
Moxifloxacin—Fatigue—Epirubicin—prostate cancer	1.33e-05	7.19e-05	CcSEcCtD
Moxifloxacin—Constipation—Epirubicin—prostate cancer	1.32e-05	7.14e-05	CcSEcCtD
Moxifloxacin—Pain—Epirubicin—prostate cancer	1.32e-05	7.14e-05	CcSEcCtD
Moxifloxacin—Nausea—Capecitabine—prostate cancer	1.31e-05	7.11e-05	CcSEcCtD
Moxifloxacin—Dizziness—Prednisone—prostate cancer	1.3e-05	7.05e-05	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.3e-05	7.03e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1A—prostate cancer	1.29e-05	0.00109	CbGpPWpGaD
Moxifloxacin—Insomnia—Doxorubicin—prostate cancer	1.29e-05	6.98e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Doxorubicin—prostate cancer	1.28e-05	6.93e-05	CcSEcCtD
Moxifloxacin—Dyspnoea—Doxorubicin—prostate cancer	1.27e-05	6.88e-05	CcSEcCtD
Moxifloxacin—Feeling abnormal—Epirubicin—prostate cancer	1.27e-05	6.88e-05	CcSEcCtD
Moxifloxacin—Somnolence—Doxorubicin—prostate cancer	1.27e-05	6.86e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Epirubicin—prostate cancer	1.26e-05	6.82e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Doxorubicin—prostate cancer	1.25e-05	6.8e-05	CcSEcCtD
Moxifloxacin—Vomiting—Prednisone—prostate cancer	1.25e-05	6.78e-05	CcSEcCtD
Moxifloxacin—Rash—Prednisone—prostate cancer	1.24e-05	6.73e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Prednisone—prostate cancer	1.24e-05	6.72e-05	CcSEcCtD
Moxifloxacin—Decreased appetite—Doxorubicin—prostate cancer	1.24e-05	6.71e-05	CcSEcCtD
Moxifloxacin—Headache—Prednisone—prostate cancer	1.23e-05	6.68e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.23e-05	6.67e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—EP300—prostate cancer	1.23e-05	0.00104	CbGpPWpGaD
Moxifloxacin—Fatigue—Doxorubicin—prostate cancer	1.23e-05	6.66e-05	CcSEcCtD
Moxifloxacin—Urticaria—Epirubicin—prostate cancer	1.22e-05	6.63e-05	CcSEcCtD
Moxifloxacin—Constipation—Doxorubicin—prostate cancer	1.22e-05	6.6e-05	CcSEcCtD
Moxifloxacin—Pain—Doxorubicin—prostate cancer	1.22e-05	6.6e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Epirubicin—prostate cancer	1.22e-05	6.6e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Epirubicin—prostate cancer	1.22e-05	6.6e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MYC—prostate cancer	1.2e-05	0.00101	CbGpPWpGaD
Moxifloxacin—Feeling abnormal—Doxorubicin—prostate cancer	1.17e-05	6.36e-05	CcSEcCtD
Moxifloxacin—Nausea—Prednisone—prostate cancer	1.17e-05	6.34e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Doxorubicin—prostate cancer	1.16e-05	6.31e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Epirubicin—prostate cancer	1.13e-05	6.15e-05	CcSEcCtD
Moxifloxacin—Urticaria—Doxorubicin—prostate cancer	1.13e-05	6.13e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Doxorubicin—prostate cancer	1.13e-05	6.1e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Doxorubicin—prostate cancer	1.13e-05	6.1e-05	CcSEcCtD
Moxifloxacin—Asthenia—Epirubicin—prostate cancer	1.1e-05	5.99e-05	CcSEcCtD
Moxifloxacin—Pruritus—Epirubicin—prostate cancer	1.09e-05	5.9e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—MYC—prostate cancer	1.07e-05	0.000906	CbGpPWpGaD
Moxifloxacin—Diarrhoea—Epirubicin—prostate cancer	1.05e-05	5.71e-05	CcSEcCtD
Moxifloxacin—Hypersensitivity—Doxorubicin—prostate cancer	1.05e-05	5.69e-05	CcSEcCtD
Moxifloxacin—Asthenia—Doxorubicin—prostate cancer	1.02e-05	5.54e-05	CcSEcCtD
Moxifloxacin—Dizziness—Epirubicin—prostate cancer	1.02e-05	5.52e-05	CcSEcCtD
Moxifloxacin—Pruritus—Doxorubicin—prostate cancer	1.01e-05	5.46e-05	CcSEcCtD
Moxifloxacin—Vomiting—Epirubicin—prostate cancer	9.78e-06	5.31e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Doxorubicin—prostate cancer	9.74e-06	5.28e-05	CcSEcCtD
Moxifloxacin—Rash—Epirubicin—prostate cancer	9.7e-06	5.26e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Epirubicin—prostate cancer	9.69e-06	5.26e-05	CcSEcCtD
Moxifloxacin—Headache—Epirubicin—prostate cancer	9.64e-06	5.23e-05	CcSEcCtD
Moxifloxacin—Dizziness—Doxorubicin—prostate cancer	9.42e-06	5.11e-05	CcSEcCtD
Moxifloxacin—Nausea—Epirubicin—prostate cancer	9.14e-06	4.96e-05	CcSEcCtD
Moxifloxacin—Vomiting—Doxorubicin—prostate cancer	9.05e-06	4.91e-05	CcSEcCtD
Moxifloxacin—Rash—Doxorubicin—prostate cancer	8.98e-06	4.87e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Doxorubicin—prostate cancer	8.97e-06	4.86e-05	CcSEcCtD
Moxifloxacin—Headache—Doxorubicin—prostate cancer	8.92e-06	4.84e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—TP53—prostate cancer	8.79e-06	0.000744	CbGpPWpGaD
Moxifloxacin—Nausea—Doxorubicin—prostate cancer	8.46e-06	4.59e-05	CcSEcCtD
